Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Genomic and Pathological Consequences of Obesity on Prostate Cancer

FY 2018-19

Summary
More than 1 in 3 Canadians are living with obesity and half will be diagnosed with cancer in their lifetimes. Obesity increases the risk of prostate cancer, and in particular aggressive disease that is not cured by standard treatment. It is still unclear what influences obesity is playing on prostate cancer risk and aggression. My project seeks to answer this question by applying new DNA sequencing techniques and state-of-the-art machine learning to study the prostate tumours of obese and non-obese men. In each cell, the information that passes down from parents to child is encoded in the DNA. Some genes (pieces of DNA) that are passed down increase a person's risk for obesity or cancer, and during a person's lifetime genetic changes can make cells turn cancerous. My first question is: Compared to non-obese men, do obese men carry unique genetic changes in their cancers, or do they have changes that are more frequently found in aggressive cancers? Second: What patterns in inherited genes are shared between people who have high risks for both obesity and prostate cancer? Finally: How different do tumour cells appear in men with and without obesity? I will link these questions to clinical outcomes to understand their importance to prevention and patient care. The answers to these questions are critical for better predicting outcomes of patients with both obesity and prostate cancer, for helping doctors make better treatment decisions, and for more cost-effective diagnosis through microscopes. This study will be the first to look at the relationship between obesity and the genetic features of prostate cancer. By understanding how and why prostate cancer differs in obese men, scientists can better understand how prostate cancers develop and how to better match obese patients to the targeted therapy most likely to cure their disease. This research will be vital for improving the care and treatment of thousands of Canadians affected by both obesity and prostate cancer.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
396637
Name
Liu Yiyang
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Genomic and Pathological Consequences of Obesity on Prostate Cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Artificial Intelligence; Biostatistics; Computational Modeling; Genomics; Machine-Learning; Obesity; Predictive Biology; Prostate Cancer
Abstract
More than 1 in 3 Canadians are living with obesity and half will be diagnosed with cancer in their lifetimes. Obesity increases the risk of prostate cancer, and in particular aggressive disease that is not cured by standard treatment. It is still unclear what influences obesity is playing on prostate cancer risk and aggression. My project seeks to answer this question by applying new DNA sequencing techniques and state-of-the-art machine learning to study the prostate tumours of obese and non-obese men. In each cell, the information that passes down from parents to child is encoded in the DNA. Some genes (pieces of DNA) that are passed down increase a person's risk for obesity or cancer, and during a person's lifetime genetic changes can make cells turn cancerous. My first question is: Compared to non-obese men, do obese men carry unique genetic changes in their cancers, or do they have changes that are more frequently found in aggressive cancers? Second: What patterns in inherited genes are shared between people who have high risks for both obesity and prostate cancer? Finally: How different do tumour cells appear in men with and without obesity? I will link these questions to clinical outcomes to understand their importance to prevention and patient care. The answers to these questions are critical for better predicting outcomes of patients with both obesity and prostate cancer, for helping doctors make better treatment decisions, and for more cost-effective diagnosis through microscopes. This study will be the first to look at the relationship between obesity and the genetic features of prostate cancer. By understanding how and why prostate cancer differs in obese men, scientists can better understand how prostate cancers develop and how to better match obese patients to the targeted therapy most likely to cure their disease. This research will be vital for improving the care and treatment of thousands of Canadians affected by both obesity and prostate cancer.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Liu, Yiyang
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
University of Toronto - $150,000 Grant (2018-19) | Canada Spends